Argenx
ARGX
#407
Rank
โ‚ฌ48.94 B
Marketcap
785,90ย โ‚ฌ
Share price
-0.63%
Change (1 day)
32.22%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Market capitalization of Argenx (ARGX)

Market cap: โ‚ฌ48.94 Billion

As of December 2025 Argenx has a market cap of โ‚ฌ48.94 Billion. This makes Argenx the world's 407th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Argenx from 2014 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚ฌ48.94 B35.99%
2024โ‚ฌ35.98 B76.3%
2023โ‚ฌ20.41 B4.48%
2022โ‚ฌ19.53 B20.32%
2021โ‚ฌ16.23 B42.44%
2020โ‚ฌ11.39 B85.66%
2019โ‚ฌ6.14 B100.34%
2018โ‚ฌ3.06 B83.42%
2017โ‚ฌ1.67 B
2014โ‚ฌ0.11 B

End of Day market cap according to different sources

On Dec 4th, 2025 the market cap of Argenx was reported to be:

โ‚ฌ47.93 Billion
by Nasdaq info icon info icon
โ‚ฌ48.94 Billion
by CompaniesMarketCap info icon info icon